Forecast

Financial forecast

Project revenue, EBITDA, net income and free cash flow for the next 5 or 10 years. Growth starts at the same rate the valuation uses and fades to the long-run rate, with margins held at today's level. Bear and bull cases move growth by the company's own revenue volatility. It is a model of what the assumptions imply, not a prediction.

GSK plc (GSK.L)

Price updated 06 Nov 2026 09:56; TTM through 30 Sep 2026; TTM financials updated 06 Nov 2026 12:56.

Starts from TTM through 30 Sep 2026 financials in GBP and a share price of GBP 18.50. Growth begins at 4.9% a year (the valuation's blended assumption) and fades to 2.9% by year 10. Margins held at EBITDA 31.7%, net 13.0%, free cash flow 20.4% of revenue. Bear and bull move starting growth by 1.5 points and long-run growth by 1 point.

Year 1 uses analyst consensus revenue growth (4.5%); year 2 is halfway back to the model's own path.
GBP 17.93Model fair value (Free-cash-flow DCF); range GBP 12.20 to GBP 27.89
-3%Fair value vs today's price
LowModel confidence
25%Share of the gap to fair value the price closes by year 5

Confidence: Earnings-based DCF is somewhat apart; trailing-twelve-month data; profit and cash flow steady for 3 years; value is more than 1.5x the Earnings-based DCF value.

6.6%/yrModel-implied annual total return over 10 years, base case (price plus dividends). Raw model level; the screener shows a calibrated ranking instead
GBP 48.86BRevenue in year 10 (base)
GBP 6.34BNet income in year 10 (base)
GBP 9.96BFree cash flow in year 10 (base)
GBP 0.96Dividend per share in year 10 (base)
GBP 26.74Implied share price in year 10 (base), today GBP 18.50
13.2%Year-10 free cash flow per share vs today's price

Free cash flow over time

GBP 0 GBP 2.81B GBP 5.61B GBP 8.42B GBP 11.23B FY2022 FY2023 FY2024 FY2025 TTM through 30 Sep 2026 +1 +2 +3 +4 +5 +6 +7 +8 +9 +10
Solid: reported Dashed: base projection Shaded: bear to bull range
Free cash flow in year 10 by scenario
CaseStarting growthYear 10Annual growth
Bear 3.0% GBP 8.82B 2.6%
Base 4.5% GBP 9.96B 3.8%
Bull 6.0% GBP 11.23B 5.1%

Base case by year

YearGrowthRevenueEBITDANet incomeFree cash flowEPSFCF / shareDividend / shareBook / shareImplied price
TTM through 30 Sep 2026– GBP 33.54BGBP 10.64BGBP 4.35BGBP 6.84B 1.071.680.664.6018.50
Year 14.5% GBP 35.05BGBP 11.12BGBP 4.55BGBP 7.15B 1.121.750.695.0319.30
Year 24.6% GBP 36.65BGBP 11.63BGBP 4.75BGBP 7.47B 1.171.830.725.4720.15
Year 34.4% GBP 38.27BGBP 12.14BGBP 4.96BGBP 7.80B 1.221.920.765.9421.01
Year 44.2% GBP 39.88BGBP 12.65BGBP 5.17BGBP 8.13B 1.272.000.796.4221.86
Year 54.0% GBP 41.47BGBP 13.16BGBP 5.38BGBP 8.45B 1.322.080.826.9222.70
Year 63.8% GBP 43.04BGBP 13.65BGBP 5.58BGBP 8.77B 1.372.150.857.4423.55
Year 73.6% GBP 44.56BGBP 14.14BGBP 5.78BGBP 9.08B 1.422.230.887.9824.39
Year 83.3% GBP 46.05BGBP 14.61BGBP 5.97BGBP 9.39B 1.472.300.918.5425.20
Year 93.1% GBP 47.49BGBP 15.06BGBP 6.16BGBP 9.68B 1.512.380.949.1125.99
Year 102.9% GBP 48.86BGBP 15.50BGBP 6.34BGBP 9.96B 1.562.450.969.7026.74

EPS and free cash flow per share assume today's share count. Dividends assume today's payout ratio and book value grows with retained earnings. The implied share price follows the valuation models and is not a price target; override growth settings do not change the model fair value. Margins stay at today's level except where the notes say they drift toward their average, so it does not model margin expansion, buybacks, acquisitions or recessions. It is for information and education only and is not investment advice. See the methodology for how the growth rate is blended.